日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

DART/SWOG/NCI II期抗CTLA-4/PD-1试验:卵巢、子宫内膜、宫颈透明细胞癌

Chae, Young Kwang; Othus, Megan; Patel, Sandip P; Backes, Floortje J; O'Malley, David M; Cristea, Mihaela; Naing, Aung; Kurnit, Katherine; Eskander, Ramez N; T Goodrich, Scott; Robinson, William R; Scalici, Jennifer; Chan, John; Ali-Ahmad, Hussein; Hays, John; McCormick, Colleen; Kim, Edward J; Sueblinvong, Thanasak; Ahmed, Amina; Siedel, Jean; Thomes Pepin, Jessica; Bottsford-Miller, Justin Neal; Fagbemi, Seth Olusegun; Jaslowski, Anthony John; Kim, Hye Sung; Chung, Liam Il-Young; Moloney-Lineen, Carolyn; McLeod, Christine M; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles D; Kurzrock, Razelle

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial

比较度伐利尤单抗、奥拉帕尼和西地尼布单药治疗、联合治疗或化疗治疗既往接受过贝伐珠单抗治疗的铂耐药卵巢癌患者的疗效:II期NRG-GY023试验

Lee, Jung-Min; Miller, Austin; Rose, Peter G; AlHilli, Mariam; Washington, Christina; John, Veena S; Shah, Chirag A; Matsuo, Koji; Siedel, Jean; Miller, David S; Hopp, Elizabeth E; O'Shea, Andrea; Chan, John K; Bradford, Leslie S; Morse, Christopher B; Nagel, Christa I; Rodabaugh, Kerry J; Kohn, Elise C; Moore, Kathleen N; Liu, Joyce F

Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression

贝伐单抗在疾病进展后的治疗:卵巢癌、输卵管癌和腹膜癌患者在疾病进展后再次接受贝伐单抗治疗的影响

Asare, Amma; Previs, Rebecca Ann; Spinosa, Daniel; Fellman, Bryan; Scott, Amelia L; Mulder, Isabelle; Mahmoud, May; Enbaya, Ahmed; Siedel, Jean Hansen; Cobb, Lauren; Soliman, Pamela T; Sood, Anil K; Coleman, Robert L; Secord, Angeles Alvarez; Westin, Shannon N

Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

奥拉帕尼治疗伴有体细胞BRCA2突变的转移性子宫腺肉瘤患者四年无复发生存期:病例报告

Foug, Katie; Skala, Stephanie L; Stien, Erica; Reynolds, Kevin; Siedel, Jean; Uppal, Shitanshu

Primary ureteral anastomosis: Ureteroureterostomy

原发性输尿管吻合术:输尿管输尿管吻合术

Batra, Sadhvi; Siedel, Jean; Hoffman, Mitchel

Internally Filled Fellowship Positions in Obstetrics and Gynecology Before and After 2020

2020年前后妇产科内部填补的专科医师培训职位

McLaughlin, Hannah D; Janke, Monica J; Uppal, Shitanshu; Roberts, Celeste; Aaron, Bryan; Spencer, Ryan J; Siedel, Jean H; Hong, Christopher X

Toward a complete understanding of quasi-static bubble growth and departure

为了全面理解准静态泡沫的生长和脱离,我们需要深入探究其机制。

Siedel, Samuel; Gu, Tianle

Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density

p14 的缺失通过非经典 Wnt 信号通路降低肽表面密度,从而减弱黑色素瘤的免疫原性。

Jonas Wohlfarth ,Corinna Kosnopfel ,Dominic Faber ,Marion Berthold ,Claudia Siedel ,Melissa Bernhardt ,Andreas Schlosser ,Tyler Aprati ,David Liu ,David Schrama ,Roland Houben ,Dirk Schadendorf ,Matthias Goebeler ,Svenja Meierjohann ,Bastian Schilling

Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients

生殖系基因检测揭示了子宫浆液性癌患者的致病变异

Tondo-Steele, Katelyn; Milliron, Kara J; Siedel, Jean H; Uppal, Shitanshu; Merajver, Sofia D; McLean, Karen

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils

黑色素瘤细胞对靶向治疗的敏感性与血液中性粒细胞的保护相关

Simone Wendlinger, Jonas Wohlfarth, Claudia Siedel, Sophia Kreft, Teresa Kilian, Sarah Junker, Luisa Schmid, Tobias Sinnberg, Ulrich Dischinger, Markus V Heppt, Kilian Wistuba-Hamprecht, Friedegund Meier, Luise Erpenbeck, Elsa Neubert, Matthias Goebeler, Anja Gesierich, David Schrama, Corinna Kosnop